Cargando…
Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial
BACKGROUND: The goal of this study was to investigate the effects of treatment with Saccharomyces boulardii and Lactobacillus reuteri on the eradication of Helicobacter pylori and Adverse effects (AEs) of the treatment. RESULTS: This study was a double-blind, randomized, placebo-controlled trial. An...
Autores principales: | Naghibzadeh, Nooshin, Salmani, Fatemeh, Nomiri, Samira, Tavakoli, Tahmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903632/ https://www.ncbi.nlm.nih.gov/pubmed/35255819 http://dx.doi.org/10.1186/s12876-022-02187-z |
Ejemplares similares
-
Non-Viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a New Approach to Helicobacter pylori Control in Humans
por: Mehling, Heidrun, et al.
Publicado: (2013) -
Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study
por: Holz, Caterina, et al.
Publicado: (2014) -
Saccharomyces boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial
por: Zhao, Yuchong, et al.
Publicado: (2021) -
Saccharomyces Boulardii in Helicobacter Pylori Eradication in Children: A Randomized Trial From Iran
por: Namkin, Kokab, et al.
Publicado: (2016) -
The efficacy and safety of Saccharomyces boulardii in addition to antofloxacin-based bismuth quadruple therapy for Helicobacter pylori eradication: a single-center, prospective randomized-control study
por: He, Xiao-Jian, et al.
Publicado: (2023)